Cyclo Therapeutics: Clinical-Stage Biotech Targeting Alzheimer's and Other Unmet Medical Needs

Oct. 4, 2019
Cyclo Therapeutics: (OTCQB: CTDH) is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease.

 Read More

Bloomberg TV Show

CEO Interviews

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market